Birth weight in offspring of mothers with polycystic ovarian syndrome

Human Reproduction

Volumn 20, Issue 8, 2005, Pages 2122-2126

  Sir Petermann, Teresa ^a   Hitchsfeld, Catalina ^a   Maliqueo, Manuel ^a   Codner, Ethel ^b   Echiburú, Bárbara ^a   Gazitúa, Raimundo ^a   Recabarren, Sergio ^c   Cassorla, Fernando ^b  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

^c UNIVERSITY OF CONCEPCIÓN   (Chile)

Author keywords

Birth weight; Macrosomia; Metformin; Polycystic ovary syndrome; Small for gestational age

Indexed keywords

ADULT; ARTICLE; BIRTH WEIGHT; BODY HEIGHT; CONTROLLED STUDY; FEMALE; FETUS GROWTH; GESTATIONAL AGE; HEAD CIRCUMFERENCE; HUMAN; MAJOR CLINICAL STUDY; MOTHER; NEWBORN; OVARY POLYCYSTIC DISEASE; PREGNANCY; PREGNANCY COMPLICATION; PREVALENCE; PROGENY; SMALL FOR DATE INFANT; BODY MASS; INCIDENCE;

ADULT; BIRTH WEIGHT; BODY HEIGHT; BODY MASS INDEX; FEMALE; HUMANS; INCIDENCE; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY COMPLICATIONS; PREVALENCE;

EID: 25144477132     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dei009     Document Type: Article

References (48)

1. Adams J, Polson DW and Franks S (1986) Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J 293,355-359.
2. Barker DJP (1994) Programming the baby. In Mothers, Babies, and Disease in Later Life. BMJ Publishing Group, London, pp. 14-36.
3. Barker DPJ and Osmond C (1986) Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet 1,1077-1081.
4. Barker DJ, Hales CN, Fall CH, Osmond C, Phipps K and Clark PM (1993) Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidemia (Syndrome X): Relation to reduced fetal growth. Diabetologia 36,62-67.
5. Bavdekar A, Yajnik CS, Fall CH, Bapat S, Pandit AN, Deshpande V, Bhave S, Kellingray SD and Joglekar C (1999) Insulin resistance syndrome in 8 year-old Indian children: Small at birth, big at 8 years, or both? Diabetes 48,2422-2429.
6. Benitez R, Sir-Petermann T, Palomino A, Angel B, Maliqueo M, Perez F and Calvillan M (2001) Prevalence of metabolic disorders among family members of patients with polycystic ovary syndrome. Rev Med Chil 129,707-712.
7. Das UG and Sysyn GD (2004) Abnormal fetal growth: Intrauterine growth retardation, small for gestational age, large for gestational age. Pediatr Clin North Am 51,639-654.
8. Davies MJ and Norman RJ (2002) Programming and reproductive functioning. Trends Endocrinol Metab 13,386-392.
9. de Bruin JP, Dorland M, Bruinse HW, Spliet W, Nikkels PG and Te Velde ER (1998) Fetal growth retardation as a cause of impaired ovarian development. Early Hum Dev 51,39-46.
10. de Rooy L and Hawdon J (2002) Nutritional factors that affect the postnatal metabolic adaptation of full-term small- and large-for-gestational-age infants. Pediatrics 109,E42.
11. Dunaif A (1997) Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18,774-800.
12. Dunaif A, Graf M, Mandeli J, Laumas V and Dobrjansky A (1987) Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J Clin Endocrinol Metab 65,499-507.
13. Dunaif A, Segal KR, Futterweit W and Dobrjansky A (1989) Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38,1165-1174.
14. Ehrmann DA, Barnes RB and Rosenfield RL (1995) Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev 16,322-353.
15. Franks S (1995) Polycystic ovary syndrome. N Engl J Med 333,853-861.
16. Glueck CJ, Goldenberg N, Wang P, Loftspring M and Sherman A (2004) Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughout pregnancy. Hum Reprod 19,510-521.
17. Gray P, Cooper PA, Cory BJ, Toman M and Crowter NJ (2002) The intrauterine environment is a strong determinant of glucose tolerance during the neonatal period, even in prematurity. J Clin Endocrinol Metab 87, 4252-4256.
18. Hattersley AT and Tooke JE (1999) The fetal insulin hypothesis: An alternative explanation of the association of low birthweight with diabetes and vascular disease. Lancet 353,1789-1792.
19. Hattersley AT, Beards F, Ballantyne E, Appleton M, Harvey R and Ellard S (1998) Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nat Genet 19,268-270.
20. Hindmarsh PC, Geary MP, Rodeck CH, Kingdom JC and Cole TJ (2002) Intrauterine growth and its relationship to size and shape at birth. Pediatr Res 52,263-268.
21. Hoffman PL, Cutfield WS, Robinson EM, Bergman RN, Menon RK, Sperling MA and Gluckman PD (1997) Insulin resistance in short children with intrauterine growth retardation. J Clin Endocrinol Metab 82,402-406.
22. Holemans K, Aerts L and Van Assche FA (1998) Fetal growth and long-term consequences in animal models of growth retardation. Eur J Obstet Gynecol Reprod Biol 81,149-156.
23. Holte J (1996) Disturbances in insulin secretion and sensitivity in women with the polycystic ovary syndrome. Baillieres Clin Endocrinol Metab 10,221-247.
24. Hübinette A, Cnattingius S, Ekbom A, de Faire U, Kramer M and Lichtenstein P (2001) Birthweight, early environment, and genetics: A study of twins discordant for acute myocardial infarction. Lancet 357,1990-1997.
25. Hull MG (1987) Epidemiology of infertility and polycystic ovarian disease: Endocrinological and demographic studies. Gynecol Endocrinol 1, 235-245.
26. Ibáñez L, Potau N, Francois I and de Zegher F (1998) Precocious pubarche, hyperinsulinism and ovarian hyperandrogenism in girls: relation to reduced fetal growth. J Clin Endocrinol Metab 83,3558-3562.
27. Ibáñez L, Potau N, Ferrer A, Rodriguez-Hierro F, Marcos MV and de Zegher F (2002b) Reduced ovulation rate in adolescent girls born small for gestational age. J Clin Endocrinol Metab 87,3391-3393.
28. Ibáñez L, Potau N, Enriquez G, Marcos MV and de Zegher F (2003) Hypergonadotrophinaemia with reduced uterine and ovarian size in women born small-for-gestational-age. Hum Reprod 18,1565-1569.
29. Ibáñez L, Valls C, Cols M, Ferrer A, Marcos MV and De Zegher F (2002a) Hypersecretion of FSH in infant boys and girls born small for gestational age. J Clin Endocrinol Metab 87,1986-1988.
30. Jaquet D, Gaboriau A, Czernichow P and Levy-Marchal C (2000) Insulin resistance early in adulthood in subjects born with intrauterine growth retardation. J Clin Endocrinol Metab 85,1401-1406.
31. Juez G, Lucero E, Ventura-Junca P, Gonzalez H, Tapia JL and Winter A (1989) Intrauterine growth in Chilean middle class newborn infants. Rev Chil Pediatr 60,198-202.
32. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR and Azziz R (1998) Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: A prospective study. J Clin Endocrinol Metab 83,3078-3082.
33. Lesser KB and Garcia FA (1997) Association between polycystic ovary syndrome and glucose intolerance during pregnancy. J Matern Fetal Med 6, 303-307.
34. Manikkam M, Crespi EJ, Doop DD, Herkimer C, Lee JS, Yu S, Brown MB, Foster DL and Padmanabhan V (2004) Fetal programming: Prenatal testosterone excess leads to fetal growth retardation and postnatal catch-up growth in sheep. Endocrinology 145,790-798.
35. Ong KK and Dunger DB (2002) Perinatal growth failure: The road to obesity, insulin resistance and cardiovascular disease in adults. Best Pract Res Clin Endocrinol Metab 16,191-207.
36. Rhind SM, Rae MT and Brooks AN (2001) Effects of nutrition and environmental factors on the fetal programming of the reproductive axis. Reproduction 122,205-214.
37. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19,41-47.
38. Sir-Petermann T, Devoto L, Maliqueo M, Peirano P, Recabarren SE and Wildt L (2001) Resumption of ovarian function during lactational amenorrhoea in breastfeeding women with polycystic ovary syndrome: endocrine aspects. Hum Reprod 16,1603-1610.
39. Sir-Petermann T, Maliqueo M, Angel B, Lara HE, Perez-Bravo F and Recabarren SE (2002) Maternal serum androgens in pregnant women with polycystic ovarian syndrome: Possible implications in prenatal androgenization. Hum Reprod 17,2573-2579.
40. Soto N, Bazaes RA, Pena V, Salazar T, Avila A, Iniguez G, Ong KK, Dunger DB and Mericq MV (2003) Insulin sensitivity and secretion are related to catch-up growth in small-for gestational-age infants at age 1 year: results from a prospective cohort. J Clin Endocrinol Metab 88, 3645-3650.
41. Tchernitchin AN, Tchernitchin NN, Mena MA, Unda C and Soto J (1999) Imprinting: Perinatal exposures cause the development of diseases during the adult age. Acta Biol Hung 50,425-440.
42. Temple IK, James RS, Crolla JA, Sitch FL, Jacobs PA, Howell WM, Betts P, Baum JD and Shield JP (1995) An imprinted gene(s) for diabetes? Nat Genet 9,110-112.
43. Temple IK, Gardner RJ, Robinson DO, Kibirige MS, Ferguson AW, Baum JD, Barber JC, James RS and Shield JP (1996) Further evidence for an imprinted gene for neonatal diabetes localised to chromosome 6q22-q23. Hum Mol Genet 5,1117-1124.
44. Thomas PM, Cote GJ, Wohllk N, Haddad B, Mathew PM, Rabl W, Aguilar-Bryan L, Gagel RF and Bryan J (1995) Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science 286,426-429.
45. Urman B, Sarac E, Dogan L and Gurgan T (1997) Pregnancy in infertile PCOD patients. Complications and outcome. J Reprod Med 42,501-505.
46. World Health Organization (1999) Report of a WHO consultation: definition, diagnosis and Classification of Diabetes Mellitus and its complications. In Part I: Diagnosis and classification of diabetes mellitus. World Health Organization, Department of Noncommunicable Disease Surveillance, Geneva.
47. Wortsman J, de Angeles S, Futterweit W, Singh KB and Kaufmann RC (1991) Gestational diabetes and neonatal macrosomia in the polycystic ovary syndrome. J Reprod Med 36,659-661.
48. Zawadzki JK and Dunaif A (1992) Diagnostic criteria for polycystic ovary syndrome: Towards a rational approach. In Hershmann JM (ed.) Current Issues in Endocrinology and Metabolism. Blackwell, Boston, pp. 377-384.